Bone marrow stromal cells in fibrous dysplasia produce excess amounts of the phosphate-regulating hormone fibroblast growth factor-23 (FGF23), leading to loss of phosphate in the urine.[7] Patients with hypophosphatemia may develop rickets/osteomalacia, increased fractures, and bone pain.[8]